| # | Title | Journal | Year | Citations |
|---|
| 1 | Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial | Lancet, The | 2001 | 328 |
| 2 | Pravastatin Therapy and the Risk of Stroke | New England Journal of Medicine | 2000 | 302 |
| 3 | Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis | Circulation | 2003 | 277 |
| 4 | Long-term outcome after the mustard repair for simple transposition of the great arteries | Journal of the American College of Cardiology | 1998 | 202 |
| 5 | Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation | Journal of the American College of Cardiology | 2003 | 175 |
| 6 | After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study. | Circulation | 1993 | 157 |
| 7 | Gender and Acute Myocardial Infarction: Is There a Different Response to Thrombolysis? | Journal of the American College of Cardiology | 1997 | 140 |
| 8 | Clinical implications of the new definition of myocardial infarction | British Heart Journal | 2004 | 128 |
| 9 | Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal | Catheterization and Cardiovascular Interventions | 2007 | 106 |
| 10 | Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression | American Journal of Cardiology | 1999 | 102 |
| 11 | End-systolic volume and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function. | Circulation | 1994 | 95 |
| 12 | Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial | Lancet, The | 1997 | 95 |
| 13 | Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction | BMJ: British Medical Journal | 1996 | 86 |
| 14 | Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: Effects of antiplatelet therapy | Journal of the American College of Cardiology | 1995 | 74 |
| 15 | Prevalence of factor v leiden and prothrombin variant g20210a in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction | Journal of the American College of Cardiology | 2000 | 71 |
| 16 | Relation of left ventricular sphericity to 10-year survival after acute myocardial infarction | American Journal of Cardiology | 2004 | 71 |
| 17 | Efficacy and dosage of enalapril in congenital and acquired heart disease. | Archives of Disease in Childhood | 1994 | 67 |
| 18 | Echocardiographic diagnosis of subclincal carditis in acute rheumatic fever | International Journal of Cardiology | 1995 | 63 |
| 19 | Doppler echocardiography and the early diagnosis of carditis in acute rheumatic fever | Australian and New Zealand Journal of Medicine | 1994 | 61 |
| 20 | What cardiologists need to know about diabetes | Lancet, The | 1997 | 61 |
| 21 | Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance | American Journal of Cardiology | 1989 | 60 |
| 22 | Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation | American Journal of Cardiology | 2003 | 50 |
| 23 | Effect of aortic valve replacement on c-reactive protein in nonrheumatic aortic stenosis | American Journal of Cardiology | 2003 | 45 |
| 24 | The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes | Journal of the American College of Cardiology | 2002 | 43 |
| 25 | Candesartan and heart failure: the allure of CHARM | Lancet, The | 2003 | 38 |
| 26 | Angiographic regression of cardiac allograft vasculopathy after introducing sirolimus immunosuppression | Journal of Heart and Lung Transplantation | 2003 | 36 |
| 27 | Survival 12 years after randomization to streptokinase: the influence of thrombolysis in myocardial infarction flow at three to four weeks | Journal of the American College of Cardiology | 1999 | 35 |
| 28 | The evolving role of direct thrombin inhibitors in acute coronary syndromes | Journal of the American College of Cardiology | 2003 | 35 |
| 29 | Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors? | Lancet, The | 2003 | 35 |
| 30 | Early ST-segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction | American Heart Journal | 2002 | 34 |
| 31 | Serum enzymes after cardiac surgery using cardiopulmonary bypass | American Heart Journal | 1974 | 31 |
| 32 | Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction | Journal of the American College of Cardiology | 2000 | 30 |
| 33 | Transcatheter closure of a large coronary artery fistula with the Amplatzer duct occluder | Catheterization and Cardiovascular Interventions | 1999 | 29 |
| 34 | Heart Dipole Regions and the Measurement of Dipole Moment | Nature | 1961 | 27 |
| 35 | Things ain't what they used to be: Impact of a new definition of myocardial infarction | American Heart Journal | 2002 | 26 |
| 36 | Acute hemodynamic effects of converting enzyme inhibition in children with intracardiac shunts | Pediatric Cardiology | 1992 | 26 |
| 37 | Unmet Therapeutic Needs in the Management of Acute Ischemia | American Journal of Cardiology | 1997 | 25 |
| 38 | Future of reperfusion therapy for acute myocardial infarction | Lancet, The | 1999 | 23 |
| 39 | New Q waves on the presenting electrocardiogram independently predict increased cardiac mortality following a first ST-elevation myocardial infarction | European Heart Journal | 2000 | 23 |
| 40 | Direct thrombin inhibition and thrombolytic therapy: rationale for the hirulog and early reperfusion/occlusion (HERO-2) trial | American Journal of Cardiology | 1998 | 19 |
| 41 | Angioplasty versus bypass surgery | Lancet, The | 1995 | 18 |
| 42 | Role of echocardiography in acute coronary syndromes | British Heart Journal | 2002 | 18 |
| 43 | Experimental comparison of “parallel grid leads” with simple bipolar, and the SVEC-III, Frank, and McFee-Parungao systems | American Heart Journal | 1965 | 16 |
| 44 | MECHANISM OF LATE BENEFIT IN ISIS-2 | Lancet, The | 1988 | 16 |
| 45 | Aspirin or warfarin for non-rheumatic atrial fibrillation? | Lancet, The | 1994 | 15 |
| 46 | Effects of streptokinase in patients presenting within 6 hours of prolonged chest pain with ST segment depression. | Heart | 1995 | 15 |
| 47 | Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions | Expert Opinion on Pharmacotherapy | 2002 | 15 |
| 48 | Coronary atheroma regression trials | Lancet, The | 1992 | 14 |
| 49 | Good long‐term outcome following surgical repair of post‐infarction ventricular septal defect | Australian and New Zealand Journal of Medicine | 1995 | 14 |
| 50 | Optimal treatment of patients with acute coronary syndromes and non–ST-elevation myocardial infarction | American Heart Journal | 1999 | 14 |
